ACCELERATING MEDICAL INNOVATION
LIVE

Serial Number

77600170

Owner

BEAUFORT, LLC

Attorney

Robert J. Kenney

First Use Date

Jun 25, 2009

Filing Date

Oct 24, 2008

Add to watchlist:

No watchlists yet
View on USPTO

ACCELERATING MEDICAL INNOVATION Trademark

Serial Number: 77600170 • Registration: 3825874

ACCELERATING MEDICAL INNOVATION is a trademark filed by BEAUFORT, LLC on October 24, 2008. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BEAUFORT, LLC (4 trademarks)

999 Waterside Drive, Suite 1010
NORFOLK, VA 23510

Entity Type: 16

Beaufort Advisors, LLC (3 trademarks)

Attn.: Bill Young, VP, Operations
Norfolk, VA 23510

Entity Type: 16

Trademark Details

Filing Date

October 24, 2008

Registration Date

July 27, 2010

First Use Anywhere

June 25, 2009

First Use in Commerce

June 25, 2009

Published for Opposition

July 14, 2009

Goods & Services

Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics

Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management

Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 10, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 10, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 10, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 16, 2019 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 16, 2019 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 16, 2019 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 16, 2019 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 9, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 27, 2019 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 20, 2016 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 20, 2016 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 19, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 19, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 19, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 19, 2016 E815
REGISTERED-PRINCIPAL REGISTER
Jul 27, 2010 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 19, 2010 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jun 18, 2010 REGV
ASSIGNED TO LIE
Jun 18, 2010 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 3, 2010 CNPR
ASSIGNED TO EXAMINER
May 19, 2010 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Apr 26, 2010 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 26, 2010 AITU
USE AMENDMENT FILED
Apr 8, 2010 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 8, 2010 EISU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 7, 2010 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 6, 2010 EXRA
SOU EXTENSION 1 GRANTED
Apr 2, 2010 EX1G
SOU EXTENSION 1 FILED
Apr 2, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 2, 2010 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 6, 2009 NOAM
PUBLISHED FOR OPPOSITION
Jul 14, 2009 PUBO
NOTICE OF PUBLICATION
Jun 24, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 8, 2009 PREV
ASSIGNED TO LIE
Jun 8, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2009 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2009 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2009 CNRT
ASSIGNED TO EXAMINER
Jan 27, 2009 DOCK
NEW APPLICATION ENTERED
Oct 28, 2008 NWAP